FibroGen
FGEN
#9826
Rank
HK$0.21 B
Marketcap
HK$2.18
Share price
-4.86%
Change (1 day)
-82.40%
Change (1 year)

Operating Margin for FibroGen (FGEN)

Operating Margin as of April 2025 (TTM): -517.78%

According to FibroGen's latest financial reports and stock price the company's current Operating Margin is -517.78%. At the end of 2024 the company had an Operating Margin of -489.92%.

Operating Margin history for FibroGen from 2014 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-489.92%-27.24%
2023-673.31%222.93%
2022-208.50%70.04%
2021-122.62%16.03%
2020-105.68%267.57%
2019-28.75%-18.5%
2018-35.28%-58.31%
2017-84.62%226.94%
2016-25.88%-37.18%
2015-41.20%17.15%
2014-35.17%747.31%
2013-4.15%-87.91%
2012-34.35%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-26.96%-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-226.57%-56.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-503.92%-2.68%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.